
South Africa Launches Lenacapavir HIV Prevention Program as Experts Highlight Its Potential to Reduce New Infections
The national rollout of Lenacapavir HIV prevention programs in South Africa marks a significant development in the global fight against HIV. Health authorities have begun introducing the long-acting injectable medication across hundreds of healthcare facilities. As a result, they are offering a new prevention strategy that requires only two injections











